Pregnancy Outcomes in Rats Treated With 70% Alcoholic <i>Rhamnus prinoides</i> Leaf Extract: Evidence From a Teratogenicity Study

Background Rhamnus prinoides is widely used to produce traditional beverages consumed by pregnant women and for the treatment of various diseases. Scientific evidence regarding the safety profile, especially during pregnancy, of R. prinoides is limited. Thus, this study investigated the toxic effect of R. prinoides on pregnancy outcomes. Material and Methods Pregnant rats were assigned to three treatment groups and one control group. Each rat in the treatment groups was medicated with low (250 mg/kg), middle (500 mg/kg), and high (1000 mg/kg) doses of 70% alcoholic R. prinoides extract, while the control rats received distilled water. The treatment was administered from Day 6–12 of gestation. Food intake and weight gain of the pregnant dam were measured. At Day 20 of gestation, pregnant rats were sacrificed by an overdose of anesthesia to expose the gravid uterus. The number of resorptions, implantation sites, and live fetuses, as well as the weight and crown rump length of the fetuses, were measured. Fetuses were also examined for any external, visceral, and skeletal malformations. In addition, the placenta was investigated for histopathological changes. Results Pregnant rats’ feeding status and body weight progression during gestation were not significantly affected by the administration of R. prinoides . The number of resorption sites and live fetuses, as well as the crown rump length of the fetuses, were significantly diminished in rats treated with 1000 mg/kg of R. prinoides extract compared to the control groups. The other parameters did not show significant variation between the treatment and control groups. Similarly, no significant malformations were observed in the structure of the placenta, skeleton, or visceral organs of the fetuses. Conclusion Consumption of R. prinoides in higher doses may hamper the receptive capacity of the uterus and the development of rat fetuses. Therefore, it is not recommended to use R. prinoides leaves at high doses during pregnancy.

Authors

Institutions

Publication Details

Journal
Journal of Toxicology
Published
2026-01-01
DOI
https://doi.org/10.1155/jt/4459921
Primary Topic
Phytochemical and Pharmacological Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pregnancy Outcomes in Rats Treated With 70% Alcoholic Rhamnus prinoides Leaf Extract: Evidence From a Teratogenicity Study

Abiy Abebe
Journal of Toxicology
Phytochemical and Pharmacological Studies
article

Pregnancy Outcomes in Rats Treated With 70% Alcoholic Rhamnus prinoides Leaf Extract: Evidence From a Teratogenicity Study

Abiy Abebe
article en

Abstract

Background Rhamnus prinoides is widely used to produce traditional beverages consumed by pregnant women and for the treatment of various diseases. Scientific evidence regarding the safety profile, especially during pregnancy, of R. prinoides is limited. Thus, this study investigated the toxic effect of R. prinoides on pregnancy outcomes. Material and Methods Pregnant rats were assigned to three treatment groups and one control group. Each rat in the treatment groups was medicated with low (250 mg/kg), middle (500 mg/kg), and high (1000 mg/kg) doses of 70% alcoholic R. prinoides extract, while the control rats received distilled water. The treatment was administered from Day 6–12 of gestation. Food intake and weight gain of the pregnant dam were measured. At Day 20 of gestation, pregnant rats were sacrificed by an overdose of anesthesia to expose the gravid uterus. The number of resorptions, implantation sites, and live fetuses, as well as the weight and crown rump length of the fetuses, were measured. Fetuses were also examined for any external, visceral, and skeletal malformations. In addition, the placenta was investigated for histopathological changes. Results Pregnant rats’ feeding status and body weight progression during gestation were not significantly affected by the administration of R. prinoides . The number of resorption sites and live fetuses, as well as the crown rump length of the fetuses, were significantly diminished in rats treated with 1000 mg/kg of R. prinoides extract compared to the control groups. The other parameters did not show significant variation between the treatment and control groups. Similarly, no significant malformations were observed in the structure of the placenta, skeleton, or visceral organs of the fetuses. Conclusion Consumption of R. prinoides in higher doses may hamper the receptive capacity of the uterus and the development of rat fetuses. Therefore, it is not recommended to use R. prinoides leaves at high doses during pregnancy.

Journal of ToxicologyVol. 2026(1)
Wollo University (ET)
Good health and well-being
Openalex Percentile: Top 7%
Phytochemical and Pharmacological Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pregnancy Outcomes in Rats Treated With 70% Alcoholic <i>Rhamnus prinoides</i> Leaf Extract: Evidence From a Teratogenicity Study — Abiy Abebe · Journal of Toxicology (2026) | TGRS Research Map | TGRS